Donate
Home
About AKA
Mission
Leadership
Legal
Financial
Privacy Policy
Statement of Principles
Contact
Advocacy
Donate
KCPA in UTAH
Updates
KCC
KCC Toolkit
Advocacy Toolkit
Science
AKA in Your State
Fundraising Policy
Truth in Labeling
Media
Releases
news
Videos
Resources
Congressional Briefings
AKA Testimonial Videos
AKA Media Packet
COVID-19 Support Stories
Forum
Join
Vendor
AKA GMP Program
GMP Participants
Retailer Resources
Kratom Vendor Sign-up
Kratom Consumer Champions
Events
The American Kratom Association Media Packet
NIDA Website Update Sept. 20, 2018 reviewing the alleged 44 deaths FDA claims are associated with kratom use.
Johns Hopkins Kratom User Survey
CDC Report on kratom deaths
Reply to CDC reportReply to CDC report
Dr. Jack Henningfield 8-Factor Analysis on Kratom
Hemby Study
Yue Study
FY2020 Labor HHS Appropriations Report
Briefing Memorandum on Kratom
Dr. Jane Babin Report: FDA Fails to Follow the Science
Lydecker Study on &-OH Adulteration
FDA Adverse Event Report on comparative deaths: Mitragynine, Ibuprofen, OxyContin, Tramadol, and Fenanyl
Utah Kratom Consumer Protection Act – KCPA (this is the framework for the other 4 states – Georgia, Arizona, Utah, and Nevada (so far).
DAYS THE FDA HAS IGNORED AKA’S MEETING REQUEST
.
Countup
About Us
About AKA
Good Manufacturing Processes
Our Mission
Leadership
Your Help
Donate
Financial
Privacy Policy
Our Impact
Stay Informed
Tell your Story
Follow the Science
Search
Home
About AKA
Mission
Leadership
Legal
Financial
Privacy Policy
Statement of Principles
Contact
Advocacy
Donate
KCPA in UTAH
Updates
KCC
KCC Toolkit
Advocacy Toolkit
Science
AKA in Your State
Fundraising Policy
Truth in Labeling
Media
Releases
news
Videos
Resources
Congressional Briefings
AKA Testimonial Videos
AKA Media Packet
COVID-19 Support Stories
Forum
Join
Vendor
AKA GMP Program
GMP Participants
Retailer Resources
Kratom Vendor Sign-up
Kratom Consumer Champions
Events
Donate